1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Association of EMs with rHEa
EM Unadjusted Adjustedb OR (95% CI) P Value OR (95% CI) P Value Barras density 1.96 (0.95–4.08) .07 1.11 (0.46–2.66) .81 Black hole 8.66 (2.15–58.14) .007c 5.62 (1.23–40.23) .03c Blend 2.90 (1.08–8.38) .04c 1.45 (0.43–4.99) .55 Fluid level 0.38 (0.06–1.67) .25 0.35 (0.05–1.60) .18 Hypodensity 3.18 (1.49–6.93) .003c 2.01 (0.77–5.31) .15 Swirl 1.91 (0.87–4.37) .12 1.20 (0.48–3.05) .70 Barras shape 2.41 (1.17–5.10) .02c 1.48 (0.63–3.51) .37 Island 1.37 (0.53–3.55) .51 0.49 (0.12–1.72) .27 Satellite 2.84 (1.29–6.61) .01c 1.73 (0.68–4.57) .25 Combined EMs Any shape marker 2.90 (1.26–7.18) .02c 1.87 (0.69–5.38) .22 Any density marker 1.76 (0.74–4.44) .21 0.93 (0.34–2.68) .90 Shape marker count 1.57 (1.11–2.27) .01c 1.17 (0.73–1.87) .51 Density marker count 1.51 (1.16–1.99) .003c 1.27 (0.87–1.86) .21 Any EM 2.38 (0.85–7.75) .12 1.33 (0.41–4.87) .64 EM count 1.33 (1.12–1.60) .002c 1.20 (0.91–1.58) .20 Expansion-prone hematoma 2.50 (1.16–5.50) .02c 1.30 (0.45–3.69) .63
↵a Revised hematoma expansion was defined as any of a ≥ 6-mL or ≥33% increase in ICH volume, a ≥ 1-mL increase in intraventricular hemorrhage volume, or de novo intraventricular hemorrhage.
↵b Adjusted for antiplatelet use, anticoagulant use, baseline ICH volume, and last-seen-well to initial CT.
↵c P < .05.